Journal profile · Endocrinology & Metabolism
Pituitary
ISSN 1386-341X · eISSN 1573-7403 · Springer US · UNITED STATES · Quarterly · Founded 1998
Pituitary: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 3.75; hybrid open access; APC about USD 4,490; median 48 days to acceptance (56 articles, last 24 months); community-reported acceptance: about 75%; 138 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Pituitary is published by Springer US and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Pituitary Gland Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors and Adrenal and Paraganglionic Tumors, together about 63.3% of its articles. Its main subfields are Endocrinology, Diabetes and Metabolism. (generated from OpenAlex topic counts and CAS ranking data)
Overview Pituitary publishes basic and clinical articles in all fields of neuroendocrinology on pathophysiology, diagnosis and treatment of pituitary diseases focusing on endocrine, neuroradiological, neurosurgical, pathological and radiotherapy aspects. Pituitary founded by Shlomo Melmed in 1998 is the official journal of the Pituitary Society and the Growth Hormone Research Society. Pituitary publishes articles on pathophysiological interactions of pituitary axes with metabolic signals, or non-classical endocrine systems as heart and bone. Pituitary is also devoted to developing areas of neuroendocrinology–such as the pituitary involvement in infectious diseases like COVID-19. Authors can contribute to the Journal choosing among several categories the one which best fits with their submission. The Editorial team is committed to rapid turnaround time and insightful peer review of submitted manuscripts. AIM AND SCOPES The journal considers articles in all fields of neuroendocrinology including but not limited to: Physiological regulation of pituitary hormone secretion and action; Mechanisms underlying pituitary diseases; Diagnosis and treatment of pituitary diseases; Pharmacological trials in pituitary diseases; Systemic comorbidities of pituitary diseases; Pituitary involvement in systemic diseases; Metabolic effects of pituitary hormones; Guidelines/Position Statements in pituitary diseases; Methodological advances (experimental and clinical) in pituitary disorders.
From the journal's Aims & Scope
Research area (LetPub): Endocrinology & Metabolism
Editor-in-chief Andrea GiustinaPublisher website
Editorial board by country: none in mainland China; most named United States 21, Italy 17, Spain 4, France 2, Sweden 2 (58 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Pituitary Gland Disorders and TreatmentsMedicine35.6%
- Growth Hormone and Insulin-like Growth FactorsMedicine18.4%
- Adrenal and Paraganglionic TumorsMedicine9.3%
- Adrenal Hormones and DisordersMedicine7.1%
- Glioma Diagnosis and TreatmentMedicine4.4%
- Meningioma and schwannoma managementMedicine4.4%
- Neuroendocrine Tumor Research AdvancesMedicine3.4%
- Head and Neck Surgical OncologyMedicine2.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Endocrinology & Metabolism | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Endocrinology & Metabolism | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, AGRICOLA, Naver, OCLC, Portico, CLOCKSS, Semantic Scholar
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.75LetPub ·
- Impact factor (publisher) 2025
- 3.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.9Publisher website ·
- CiteScore 2026-06
- 6.4LetPub ·
- SJR 2026-06
- 1.16LetPub ·
- SNIP 2026-06
- 1.46LetPub ·
- h-index
- 57LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 1,356OpenAlex ·
- 2-year mean citedness
- 3.14OpenAlex ·
- Self-citation rate
- 15.8%LetPub ·
- Share of gold OA articles
- 41.61%LetPub ·
Volume
- Articles per year
- 116LetPub ·
- Downloads per year (publisher) 2025
- 538,800Publisher website ·
Articles by year OpenAlex count · 2,082 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 136 | 66 | 78 |
| 2025 | 138 | 84 | 435 |
| 2024 | 111 | 61 | 695 |
| 2023 | 76 | 29 | 972 |
| 2022 | 98 | 40 | 1,658 |
| 2021 | 83 | 46 | 1,799 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
48 daysMedian, submission to acceptance · P25–P75 32 days – 73 days
- Acceptance to online
- median 20 days (97 articles)
- Submission to online
- median 72 days
- Sample
- 56 articles with submission and acceptance dates (296 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- about 6 monthsLetPub ·
- Average acceptance (community reports)
- 75%LetPub ·
- Submission to first decision
- 1 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,490 / EUR 3,790 / GBP 2,990 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Open calls for papers1, by deadline
- Sellar and Parasellar LesionsDeadline
What to prepare3 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 3,500 words
Article types accepted14, with length limits
- brief reportcs, or that present a proof of concept. Brief reports should be presented in a very concise way (limit of 1200 words (excluding abstract, references, and table/…main text ≤ 1,200 words · references ≤ 30
- editorialPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …main text ≤ 3,500 words · references ≤ 30
- forumThese contributions no longer than 1000 words could be solicited by the Editor-in-Chief or proposed by the partner Society (eicpituitary@gmail.com).main text ≤ 1,000 words
- guidelinesThis type of article should not exceed 3000 words and 250 references.main text ≤ 3,000 words · references ≤ 250
- innovationThis type of article has a word limit of 2000 and no more than 100 references with at least 1 Figure or 1 Table.main text ≤ 2,000 words · references ≤ 100
- letter to the editorText is limited to 700 words, with no abstract. There may be 1 figure or 1 Table, up to 3 references, and no more than 3 authors, with author affiliations only …main text ≤ 700 words · references ≤ 3
- letters to the editorPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …Length not stated
- meta-analysisPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …main text ≤ 3,000 words · references ≤ 100
- methodologyThis type of article has a word limit of 1500, 1 figure or table and no more than 30 references.main text ≤ 1,500 words · references ≤ 30
- mini-reviewThis type of article has a word limit of 2000 and no more than 100 references with at least 1 Figure or 1 Table.main text ≤ 2,000 words · references ≤ 100
- perspectiveThis type of article has a word limit of 1500, 1 figure or table and no more than 30 references with 1 Figure or 1 Table.main text ≤ 1,500 words · references ≤ 30
- regular articlePituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …Length not stated
- research articleManuscripts should not exceed 4,000 words, 60 references, and maximum 5 tables/figures.main text ≤ 4,000 words · references ≤ 60
- reviewPituitary publishes original basic and applied work in the field of hypothalamic-pituitary molecular biology, biochemistry, pathophysiology, clinical diagnosis …main text ≤ 3,500 words · references ≤ 200
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Peer review, Trial registration / reporting guidelines
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
Data transparency Model summary
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
Retrospective ethics approval Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in Pituitary, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Suggesting / excluding reviewers Model summary
Authors are welcome to suggest suitable reviewers and/or request the exclusion of certain individuals when they submit their manuscripts.
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 1998
- ISSN
- 1386-341X
- Electronic ISSN
- 1573-7403
- Society / sponsor
- Pituitary Society and the Growth Hormone Research Society
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Pituitary
What CAS zone is Pituitary in?
In the 2025 upgraded edition of the CAS Journal Ranking, Pituitary is in Zone 2 of Medicine, and in Zone 2 of the minor category Endocrinology & Metabolism. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Pituitary?
The latest impact factor listed by LetPub is 3.75; CiteScore 6.4, h-index 100.
How long does peer review take at Pituitary?
Based on the dates recorded on 56 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 48 days (interquartile range 32–73 days); authors report an average review time of about 6 months; the community-reported acceptance is “about 75%”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of Pituitary?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 3,500 words. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of Pituitary based?
Of the 58 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (21), Italy (17) and Spain (4). Counted from the institutions listed on the board page; for reference only.
Which databases index Pituitary?
According to LetPub and DOAJ records, Pituitary is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase, CAS and Current Contents; that list has not been checked against each database.
Is Pituitary open access, and what is the APC?
Pituitary is a hybrid journal. For open-access publication: APC about USD 4,490.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .